The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Tranexamic Acid Market Research Report 2025
Synopsis
The global Oral Tranexamic Acid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need.
This report aims to provide a comprehensive presentation of the global market for Oral Tranexamic Acid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Tranexamic Acid.
Report Scope
The Oral Tranexamic Acid market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Tranexamic Acid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Tranexamic Acid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Daiichi Sankyo
Teva Pharmaceuticals
Hunan Dongting Pharmaceutical
CR Double-Crane
Shanghai Sine Pharmaceutical
Sinopharm Group
China Resources Sanjiu
Segment by Type
Tablets
Capsules
Segment by Application
Acute Bleeding
Chronic Bleeding
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Tranexamic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Tranexamic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Oral Tranexamic Acid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need.
This report aims to provide a comprehensive presentation of the global market for Oral Tranexamic Acid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Tranexamic Acid.
Report Scope
The Oral Tranexamic Acid market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Tranexamic Acid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Tranexamic Acid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Daiichi Sankyo
Teva Pharmaceuticals
Hunan Dongting Pharmaceutical
CR Double-Crane
Shanghai Sine Pharmaceutical
Sinopharm Group
China Resources Sanjiu
Segment by Type
Tablets
Capsules
Segment by Application
Acute Bleeding
Chronic Bleeding
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Tranexamic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Tranexamic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oral Tranexamic Acid Market Overview
1.1 Product Overview and Scope of Oral Tranexamic Acid
1.2 Oral Tranexamic Acid Segment by Type
1.2.1 Global Oral Tranexamic Acid Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsules
1.3 Oral Tranexamic Acid Segment by Application
1.3.1 Global Oral Tranexamic Acid Market Value by Application: (2024-2030)
1.3.2 Acute Bleeding
1.3.3 Chronic Bleeding
1.3.4 Others
1.4 Global Oral Tranexamic Acid Market Size Estimates and Forecasts
1.4.1 Global Oral Tranexamic Acid Revenue 2019-2030
1.4.2 Global Oral Tranexamic Acid Sales 2019-2030
1.4.3 Global Oral Tranexamic Acid Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Tranexamic Acid Market Competition by Manufacturers
2.1 Global Oral Tranexamic Acid Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Tranexamic Acid Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Tranexamic Acid Average Price by Manufacturers (2019-2024)
2.4 Global Oral Tranexamic Acid Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Tranexamic Acid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Tranexamic Acid, Product Type & Application
2.7 Oral Tranexamic Acid Market Competitive Situation and Trends
2.7.1 Oral Tranexamic Acid Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Tranexamic Acid Players Market Share by Revenue
2.7.3 Global Oral Tranexamic Acid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Tranexamic Acid Retrospective Market Scenario by Region
3.1 Global Oral Tranexamic Acid Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Tranexamic Acid Global Oral Tranexamic Acid Sales by Region: 2019-2030
3.2.1 Global Oral Tranexamic Acid Sales by Region: 2019-2024
3.2.2 Global Oral Tranexamic Acid Sales by Region: 2025-2030
3.3 Global Oral Tranexamic Acid Global Oral Tranexamic Acid Revenue by Region: 2019-2030
3.3.1 Global Oral Tranexamic Acid Revenue by Region: 2019-2024
3.3.2 Global Oral Tranexamic Acid Revenue by Region: 2025-2030
3.4 North America Oral Tranexamic Acid Market Facts & Figures by Country
3.4.1 North America Oral Tranexamic Acid Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Tranexamic Acid Sales by Country (2019-2030)
3.4.3 North America Oral Tranexamic Acid Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Tranexamic Acid Market Facts & Figures by Country
3.5.1 Europe Oral Tranexamic Acid Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Tranexamic Acid Sales by Country (2019-2030)
3.5.3 Europe Oral Tranexamic Acid Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Oral Tranexamic Acid Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Tranexamic Acid Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Tranexamic Acid Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Tranexamic Acid Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Oral Tranexamic Acid Market Facts & Figures by Country
3.7.1 Latin America Oral Tranexamic Acid Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Tranexamic Acid Sales by Country (2019-2030)
3.7.3 Latin America Oral Tranexamic Acid Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Tranexamic Acid Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Tranexamic Acid Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Tranexamic Acid Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Tranexamic Acid Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Tranexamic Acid Sales by Type (2019-2030)
4.1.1 Global Oral Tranexamic Acid Sales by Type (2019-2024)
4.1.2 Global Oral Tranexamic Acid Sales by Type (2025-2030)
4.1.3 Global Oral Tranexamic Acid Sales Market Share by Type (2019-2030)
4.2 Global Oral Tranexamic Acid Revenue by Type (2019-2030)
4.2.1 Global Oral Tranexamic Acid Revenue by Type (2019-2024)
4.2.2 Global Oral Tranexamic Acid Revenue by Type (2025-2030)
4.2.3 Global Oral Tranexamic Acid Revenue Market Share by Type (2019-2030)
4.3 Global Oral Tranexamic Acid Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Tranexamic Acid Sales by Application (2019-2030)
5.1.1 Global Oral Tranexamic Acid Sales by Application (2019-2024)
5.1.2 Global Oral Tranexamic Acid Sales by Application (2025-2030)
5.1.3 Global Oral Tranexamic Acid Sales Market Share by Application (2019-2030)
5.2 Global Oral Tranexamic Acid Revenue by Application (2019-2030)
5.2.1 Global Oral Tranexamic Acid Revenue by Application (2019-2024)
5.2.2 Global Oral Tranexamic Acid Revenue by Application (2025-2030)
5.2.3 Global Oral Tranexamic Acid Revenue Market Share by Application (2019-2030)
5.3 Global Oral Tranexamic Acid Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Daiichi Sankyo
6.1.1 Daiichi Sankyo Corporation Information
6.1.2 Daiichi Sankyo Description and Business Overview
6.1.3 Daiichi Sankyo Oral Tranexamic Acid Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Daiichi Sankyo Oral Tranexamic Acid Product Portfolio
6.1.5 Daiichi Sankyo Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Corporation Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Oral Tranexamic Acid Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceuticals Oral Tranexamic Acid Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Hunan Dongting Pharmaceutical
6.3.1 Hunan Dongting Pharmaceutical Corporation Information
6.3.2 Hunan Dongting Pharmaceutical Description and Business Overview
6.3.3 Hunan Dongting Pharmaceutical Oral Tranexamic Acid Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hunan Dongting Pharmaceutical Oral Tranexamic Acid Product Portfolio
6.3.5 Hunan Dongting Pharmaceutical Recent Developments/Updates
6.4 CR Double-Crane
6.4.1 CR Double-Crane Corporation Information
6.4.2 CR Double-Crane Description and Business Overview
6.4.3 CR Double-Crane Oral Tranexamic Acid Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CR Double-Crane Oral Tranexamic Acid Product Portfolio
6.4.5 CR Double-Crane Recent Developments/Updates
6.5 Shanghai Sine Pharmaceutical
6.5.1 Shanghai Sine Pharmaceutical Corporation Information
6.5.2 Shanghai Sine Pharmaceutical Description and Business Overview
6.5.3 Shanghai Sine Pharmaceutical Oral Tranexamic Acid Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shanghai Sine Pharmaceutical Oral Tranexamic Acid Product Portfolio
6.5.5 Shanghai Sine Pharmaceutical Recent Developments/Updates
6.6 Sinopharm Group
6.6.1 Sinopharm Group Corporation Information
6.6.2 Sinopharm Group Description and Business Overview
6.6.3 Sinopharm Group Oral Tranexamic Acid Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sinopharm Group Oral Tranexamic Acid Product Portfolio
6.6.5 Sinopharm Group Recent Developments/Updates
6.7 China Resources Sanjiu
6.6.1 China Resources Sanjiu Corporation Information
6.6.2 China Resources Sanjiu Description and Business Overview
6.6.3 China Resources Sanjiu Oral Tranexamic Acid Sales, Revenue and Gross Margin (2019-2024)
6.4.4 China Resources Sanjiu Oral Tranexamic Acid Product Portfolio
6.7.5 China Resources Sanjiu Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Tranexamic Acid Industry Chain Analysis
7.2 Oral Tranexamic Acid Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Tranexamic Acid Production Mode & Process
7.4 Oral Tranexamic Acid Sales and Marketing
7.4.1 Oral Tranexamic Acid Sales Channels
7.4.2 Oral Tranexamic Acid Distributors
7.5 Oral Tranexamic Acid Customers
8 Oral Tranexamic Acid Market Dynamics
8.1 Oral Tranexamic Acid Industry Trends
8.2 Oral Tranexamic Acid Market Drivers
8.3 Oral Tranexamic Acid Market Challenges
8.4 Oral Tranexamic Acid Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Oral Tranexamic Acid Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Oral Tranexamic Acid Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Oral Tranexamic Acid Market Competitive Situation by Manufacturers in 2023
Table 4. Global Oral Tranexamic Acid Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Oral Tranexamic Acid Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Oral Tranexamic Acid Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Oral Tranexamic Acid Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Oral Tranexamic Acid Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Oral Tranexamic Acid, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Tranexamic Acid, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Tranexamic Acid, Product Type & Application
Table 12. Global Key Manufacturers of Oral Tranexamic Acid, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Tranexamic Acid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Tranexamic Acid as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Tranexamic Acid Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Oral Tranexamic Acid Sales by Region (2019-2024) & (K Units)
Table 18. Global Oral Tranexamic Acid Sales Market Share by Region (2019-2024)
Table 19. Global Oral Tranexamic Acid Sales by Region (2025-2030) & (K Units)
Table 20. Global Oral Tranexamic Acid Sales Market Share by Region (2025-2030)
Table 21. Global Oral Tranexamic Acid Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Oral Tranexamic Acid Revenue Market Share by Region (2019-2024)
Table 23. Global Oral Tranexamic Acid Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Oral Tranexamic Acid Revenue Market Share by Region (2025-2030)
Table 25. North America Oral Tranexamic Acid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Oral Tranexamic Acid Sales by Country (2019-2024) & (K Units)
Table 27. North America Oral Tranexamic Acid Sales by Country (2025-2030) & (K Units)
Table 28. North America Oral Tranexamic Acid Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Oral Tranexamic Acid Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Oral Tranexamic Acid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Oral Tranexamic Acid Sales by Country (2019-2024) & (K Units)
Table 32. Europe Oral Tranexamic Acid Sales by Country (2025-2030) & (K Units)
Table 33. Europe Oral Tranexamic Acid Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Oral Tranexamic Acid Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Oral Tranexamic Acid Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Oral Tranexamic Acid Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Oral Tranexamic Acid Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Oral Tranexamic Acid Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Oral Tranexamic Acid Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oral Tranexamic Acid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Oral Tranexamic Acid Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Oral Tranexamic Acid Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Oral Tranexamic Acid Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oral Tranexamic Acid Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Oral Tranexamic Acid Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Oral Tranexamic Acid Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Oral Tranexamic Acid Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Oral Tranexamic Acid Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Oral Tranexamic Acid Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Oral Tranexamic Acid Sales (K Units) by Type (2019-2024)
Table 51. Global Oral Tranexamic Acid Sales (K Units) by Type (2025-2030)
Table 52. Global Oral Tranexamic Acid Sales Market Share by Type (2019-2024)
Table 53. Global Oral Tranexamic Acid Sales Market Share by Type (2025-2030)
Table 54. Global Oral Tranexamic Acid Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Oral Tranexamic Acid Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Oral Tranexamic Acid Revenue Market Share by Type (2019-2024)
Table 57. Global Oral Tranexamic Acid Revenue Market Share by Type (2025-2030)
Table 58. Global Oral Tranexamic Acid Price (US$/Unit) by Type (2019-2024)
Table 59. Global Oral Tranexamic Acid Price (US$/Unit) by Type (2025-2030)
Table 60. Global Oral Tranexamic Acid Sales (K Units) by Application (2019-2024)
Table 61. Global Oral Tranexamic Acid Sales (K Units) by Application (2025-2030)
Table 62. Global Oral Tranexamic Acid Sales Market Share by Application (2019-2024)
Table 63. Global Oral Tranexamic Acid Sales Market Share by Application (2025-2030)
Table 64. Global Oral Tranexamic Acid Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Oral Tranexamic Acid Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Oral Tranexamic Acid Revenue Market Share by Application (2019-2024)
Table 67. Global Oral Tranexamic Acid Revenue Market Share by Application (2025-2030)
Table 68. Global Oral Tranexamic Acid Price (US$/Unit) by Application (2019-2024)
Table 69. Global Oral Tranexamic Acid Price (US$/Unit) by Application (2025-2030)
Table 70. Daiichi Sankyo Corporation Information
Table 71. Daiichi Sankyo Description and Business Overview
Table 72. Daiichi Sankyo Oral Tranexamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Daiichi Sankyo Oral Tranexamic Acid Product
Table 74. Daiichi Sankyo Recent Developments/Updates
Table 75. Teva Pharmaceuticals Corporation Information
Table 76. Teva Pharmaceuticals Description and Business Overview
Table 77. Teva Pharmaceuticals Oral Tranexamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Teva Pharmaceuticals Oral Tranexamic Acid Product
Table 79. Teva Pharmaceuticals Recent Developments/Updates
Table 80. Hunan Dongting Pharmaceutical Corporation Information
Table 81. Hunan Dongting Pharmaceutical Description and Business Overview
Table 82. Hunan Dongting Pharmaceutical Oral Tranexamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Hunan Dongting Pharmaceutical Oral Tranexamic Acid Product
Table 84. Hunan Dongting Pharmaceutical Recent Developments/Updates
Table 85. CR Double-Crane Corporation Information
Table 86. CR Double-Crane Description and Business Overview
Table 87. CR Double-Crane Oral Tranexamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. CR Double-Crane Oral Tranexamic Acid Product
Table 89. CR Double-Crane Recent Developments/Updates
Table 90. Shanghai Sine Pharmaceutical Corporation Information
Table 91. Shanghai Sine Pharmaceutical Description and Business Overview
Table 92. Shanghai Sine Pharmaceutical Oral Tranexamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Shanghai Sine Pharmaceutical Oral Tranexamic Acid Product
Table 94. Shanghai Sine Pharmaceutical Recent Developments/Updates
Table 95. Sinopharm Group Corporation Information
Table 96. Sinopharm Group Description and Business Overview
Table 97. Sinopharm Group Oral Tranexamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Sinopharm Group Oral Tranexamic Acid Product
Table 99. Sinopharm Group Recent Developments/Updates
Table 100. China Resources Sanjiu Corporation Information
Table 101. China Resources Sanjiu Description and Business Overview
Table 102. China Resources Sanjiu Oral Tranexamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. China Resources Sanjiu Oral Tranexamic Acid Product
Table 104. China Resources Sanjiu Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Oral Tranexamic Acid Distributors List
Table 108. Oral Tranexamic Acid Customers List
Table 109. Oral Tranexamic Acid Market Trends
Table 110. Oral Tranexamic Acid Market Drivers
Table 111. Oral Tranexamic Acid Market Challenges
Table 112. Oral Tranexamic Acid Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Tranexamic Acid
Figure 2. Global Oral Tranexamic Acid Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Oral Tranexamic Acid Market Share by Type in 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Global Oral Tranexamic Acid Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Oral Tranexamic Acid Market Share by Application in 2023 & 2030
Figure 8. Acute Bleeding
Figure 9. Chronic Bleeding
Figure 10. Others
Figure 11. Global Oral Tranexamic Acid Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Oral Tranexamic Acid Market Size (2019-2030) & (US$ Million)
Figure 13. Global Oral Tranexamic Acid Sales (2019-2030) & (K Units)
Figure 14. Global Oral Tranexamic Acid Average Price (US$/Unit) & (2019-2030)
Figure 15. Oral Tranexamic Acid Report Years Considered
Figure 16. Oral Tranexamic Acid Sales Share by Manufacturers in 2023
Figure 17. Global Oral Tranexamic Acid Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Oral Tranexamic Acid Players: Market Share by Revenue in 2023
Figure 19. Oral Tranexamic Acid Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Oral Tranexamic Acid Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Oral Tranexamic Acid Sales Market Share by Country (2019-2030)
Figure 22. North America Oral Tranexamic Acid Revenue Market Share by Country (2019-2030)
Figure 23. United States Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Oral Tranexamic Acid Sales Market Share by Country (2019-2030)
Figure 26. Europe Oral Tranexamic Acid Revenue Market Share by Country (2019-2030)
Figure 27. Germany Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Netherlands Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Oral Tranexamic Acid Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Oral Tranexamic Acid Revenue Market Share by Region (2019-2030)
Figure 34. China Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Oral Tranexamic Acid Sales Market Share by Country (2019-2030)
Figure 42. Latin America Oral Tranexamic Acid Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Oral Tranexamic Acid Sales Market Share by Country (2019-2030)
Figure 47. Middle East & Africa Oral Tranexamic Acid Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Oral Tranexamic Acid Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Oral Tranexamic Acid by Type (2019-2030)
Figure 52. Global Revenue Market Share of Oral Tranexamic Acid by Type (2019-2030)
Figure 53. Global Oral Tranexamic Acid Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Oral Tranexamic Acid by Application (2019-2030)
Figure 55. Global Revenue Market Share of Oral Tranexamic Acid by Application (2019-2030)
Figure 56. Global Oral Tranexamic Acid Price (US$/Unit) by Application (2019-2030)
Figure 57. Oral Tranexamic Acid Value Chain
Figure 58. Oral Tranexamic Acid Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
